APEX THERAPEUTICS, INC.

Basic Information

20 N MERIDIAN ST
INDIANAPOLIS, IN, 46204-3008

Company Profile

n/a

Additional Details

Field Value
DUNS: 826180569
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. NIEHS- Device Agnostic Environmental/Agent Data Collection and Integration with

    Amount: $240,322.00

    DESCRIPTION (provided by applicant): Our long-term goal is to develop a novel therapeutic strategy for childhood acute lymphoblastic leukemia (ALL), with focus on relapsed T-cell leukemia. We intend t ...

    SBIR Phase I 2013 Department of Health and Human Services
  2. Redox protein APE1/Ref-1 as a target for age-related macular degeneration (AMD)

    Amount: $225,064.00

    DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is the leading cause of severe vision loss in people over age 60 and an estimated 8 million older-age Americans are at high ...

    STTR Phase I 2009 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government